Curcumin's effect in advanced and metastatic breast cancer patients treated with first or second‐line docetaxel: A randomized trial

Documenti analoghi

• The efficacy of immune checkpoint inhibitors following discontinuation for long‐term response or toxicity in advanced or metastatic non‐small‐cell lung cancers: A retrospective study
  di: Laure Vacher, et al.
  Pubblicazione: (2024)
• A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients
  di: Michael B. Lilly, et al.
  Pubblicazione: (2024)
• Observational study of clinical toxicity with different formulations of docetaxel in breast cancer patients
  di: Eva González-Haba-Peña
  Pubblicazione: (2020)
• Reconfiguration of square-tiled surfaces
  di: Delecroix, Vincent, et al.
  Pubblicazione: (2025)
• Multi-Task Multi-Behavior MAP-Elites
  di: Anne, et al.
  Pubblicazione: (2023)